Vigil Neuroscience Inc.

NASDAQ: VIGL · Real-Time Price · USD
8.05
0.00 (0.00%)
At close: Aug 04, 2025, 3:59 PM

Vigil Neuroscience Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 452K n/a n/a n/a 1.93M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 124K n/a 114K 113K 113K 113K 110K 474K 383K 274K 253K 246K 237K n/a 151K n/a n/a
Gross Profit
n/a -124K 226K -114K -113K -113K 1.82M -110K -474K -383K -274K -253K -246K -237K n/a -151K n/a n/a
Operating Income
-27.49M -23.47M -25.11M -20.68M -22.48M -21.41M -23.86M -22.32M -21.91M -20.77M -18.87M -17.64M -17.04M -15.33M -12.98M -10.74M -10.78M -7.92M
Interest Income
n/a 1.06M 1.28M 1.41M 1.25M 1.48M 1.68M 1.83M 1.75M 985K 426K 163K 32K 2K n/a n/a 1K 2K
Pretax Income
-26.66M -22.41M -23.83M -19.26M -21.23M -19.94M -22.17M -20.5M -20.17M -19.8M -18.46M -17.5M -17.02M -15.33M -12.98M -10.74M -11.37M -8.19M
Net Income
-26.66M -22.41M -23.83M -19.26M -21.23M -19.94M -22.17M -20.5M -20.17M -18.75M 14.34M -17.36M -16.99M -15.34M -12.98M -10.74M -11.37M -8.19M
Selling & General & Admin
10.08M 6.96M 6.45M 6.9M 6.83M 6.98M 6.96M 6.91M 7.01M 6.94M 6.68M 4.85M 4.95M 4.97M 3.86M 2.93M 2.13M 1.17M
Research & Development
17.41M 16.51M 18.67M 13.77M 15.54M 14.33M 16.78M 15.41M 14.9M 13.83M 12.19M 12.79M 12.1M 10.37M 9.12M 7.81M 8.65M 6.75M
Other Expenses
n/a n/a n/a n/a -3K -2K 2K -3K -7K -5K -9K -26K -5K -4K -8K -2K n/a n/a
Operating Expenses
27.49M 23.47M 25.11M 20.68M 22.36M 21.3M 23.74M 22.32M 21.91M 20.77M 18.87M 17.64M 17.04M 15.33M 12.98M 10.74M 10.78M 7.92M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1K 2K
Selling & Marketing Expenses
n/a n/a n/a n/a -113K -113K -113K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 23.47M 25.11M 20.68M 22.48M 21.41M 23.86M 22.32M 21.91M 20.77M 18.87M 17.64M 17.04M 15.33M 12.98M 10.74M 10.78M 7.92M
Income Tax Expense
n/a n/a n/a n/a n/a 69.72K n/a -110K n/a -1.04M -32.79M -137K -27K 2K n/a 2K n/a n/a
Shares Outstanding (Basic)
47.62M 46.07M 41.66M 40.58M 40.56M 39.86M 38.83M 38.81M 38.66M 38.55M 38.48M 33.3M 28.15M 26.66M 28.26M 28.26M 21.06M 21.06M
Shares Outstanding (Diluted)
47.62M 46.07M 41.66M 40.58M 40.56M 39.86M 38.83M 38.81M 38.66M 38.55M 38.48M 33.3M 28.15M 26.66M 28.26M 28.26M 21.06M 21.06M
EPS (Basic)
-0.56 -0.49 -0.57 -0.47 -0.52 -0.5 -0.57 -0.53 -0.52 -0.49 0.37 -0.52 -0.6 -0.58 -0.46 -0.38 -0.54 -0.39
EPS (Diluted)
-0.56 -0.49 -0.57 -0.47 -0.52 -0.5 -0.57 -0.53 -0.52 -0.49 0.37 -0.52 -0.6 -0.58 -0.46 -0.38 -0.54 -0.39
EBITDA
-27.49M -23.47M -25M -20.56M -22.36M -21.3M -23.74M -22.21M -21.8M -20.71M -18.85M -17.62M -17.02M -15.31M -12.96M -10.73M -10.78M n/a
EBIT
n/a -22.41M -25.11M -20.68M -22.48M -21.41M -23.86M -22.32M -21.91M -20.77M -18.87M -17.64M -17.04M -15.33M -12.98M -10.74M -10.78M -7.92M
Depreciation & Amortization
n/a 124K 113K 114K 113K 113K 113K 110K 474K 383K 274K 253K 246K 237K 15K 151K 1K 7.92M